BioVie Inc. Notes Payable, Noncurrent
BioVie Inc. (BIVI) had Notes Payable, Noncurrent of $2.97 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2024-09-30
- 2023-09-30: Notes Payable, Noncurrent $2.97M.
- 2023-06-30: Notes Payable, Noncurrent $5.23M.
- 2023-03-31: Notes Payable, Noncurrent $7.41M.
- 2022-12-31: Notes Payable, Noncurrent $13.26M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2023-09-30 | $2.97M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.23M 10-K · filed 2024-09-30 |
| 2023-03-31 | $7.41M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $13.26M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $12.73M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $12.14M 10-K · filed 2023-08-16 |
| 2022-03-31 | $11.62M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $11.11M 10-Q · filed 2022-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |